Olivier Cussenot

Q: What Schools Are Affiliated With Olivier Cussenot

Olivier Cussenot is affiliated with the following schools: Université Paris Cité, University of Poitiers, Sorbonne University

Olivier Cussenot's AcademicInfluence.com Rankings

Olivier Cussenot

Biology

#11419

World Rank

#14812

Historical Rank

Cell Biology

#574

World Rank

#587

Historical Rank

Genetics

#1232

World Rank

#1333

Historical Rank

Molecular Biology

#1753

World Rank

#1782

Historical Rank

biology Degrees

Download Badge

Biology

Olivier Cussenot's Degrees

PhD Biomedical Sciences Université Paris Cité

Why Is Olivier Cussenot Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Olivier Cussenot's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 (2007) (1156)
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. (2016) (1110)
Multiple loci identified in a genome-wide association study of prostate cancer (2008) (970)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (509)
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci (2010) (423)
Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. (1998) (353)
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. (2001) (263)
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 (2011) (246)
Identification of a new prostate cancer susceptibility locus on chromosome 8q24 (2009) (245)
VEGF overexpression in clinically localized prostate tumors and neuropilin‐1 overexpression in metastatic forms (2000) (197)
Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways (2001) (196)
A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. (2015) (194)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (186)
Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. (2008) (170)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. (2011) (157)
Mid‐term evaluation of the transobturator male sling for post‐prostatectomy incontinence: focus on prognostic factors (2011) (157)
Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. (2011) (156)
Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage (2007) (156)
Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. (1997) (153)
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite (2015) (151)
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. (2013) (149)
PTEN/MMAC1/TEP1 involvement in primary prostate cancers (1998) (149)
First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer (2015) (147)
Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. (1991) (145)
The AdVance transobturator male sling for postprostatectomy incontinence: clinical results of a prospective evaluation after a minimum follow-up of 6 months. (2009) (142)
Quantification of expression of netrins, slits and their receptors in human prostate tumors (2003) (141)
Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. (2011) (141)
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. (2021) (136)
Genome-wide association study identifies multiple loci associated with bladder cancer risk. (2014) (136)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. (2006) (129)
FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours. (2009) (125)
Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases (2010) (123)
Vitamin D receptor polymorphisms as markers in prostate cancer (1999) (121)
Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. (1995) (111)
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old (2015) (110)
Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. (2007) (109)
Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility (2009) (107)
htert expression correlates with MYC over‐expression in human prostate cancer (2000) (101)
Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma. (1996) (101)
Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens. (2007) (100)
Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate (2013) (99)
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. (2012) (97)
Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. (1997) (97)
Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma (2009) (94)
Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate (2002) (93)
Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma. (2005) (92)
Tubulocystic carcinoma of the kidney: a new entity among renal tumors (2007) (91)
The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC). (2013) (90)
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram (2012) (90)
Management of lower urinary tract symptoms related to benign prostatic hyperplasia in real-life practice in france: a comprehensive population study. (2013) (89)
Two Susceptibility Loci Identified for Prostate Cancer Aggressiveness (2015) (88)
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
Variation in KLK genes, prostate-specific antigen and risk of prostate cancer (2008) (88)
Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q (1994) (87)
Genome-wide association study identifies multiple risk loci for renal cell carcinoma (2017) (86)
Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer (2013) (83)
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (83)
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA (2004) (80)
Midterm prospective evaluation of TVT-Secur reveals high failure rate. (2010) (80)
Promoter hypermethylation in circulating blood cells identifies prostate cancer progression (2008) (80)
Methylated genes as potential biomarkers in prostate cancer (2010) (78)
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study (2013) (78)
A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. (2010) (76)
Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. (2006) (73)
Does the surgical technique for management of the distal ureter influence the outcome after nephroureterectomy? (2011) (73)
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors (1998) (73)
Early‐onset hereditary prostate cancer is not associated with specific clinical and biological features (2000) (72)
Characterization of long non‐coding RNA transcriptome in clear‐cell renal cell carcinoma by next‐generation deep sequencing (2015) (71)
Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children (1990) (70)
Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. (1995) (68)
8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy. (2013) (68)
Laser induced autofluorescence diagnosis of bladder tumors: dependence on the excitation wavelength. (1996) (67)
A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi‐institutional database analysis: proposal of patient‐specific risk identification tool (2012) (66)
Gene expression profiling in clinically localized prostate cancer: a four-gene expression model predicts clinical behavior. (2003) (66)
Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. (1994) (65)
Postoperative nomogram to predict cancer‐specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis (2014) (64)
Molecular and histological markers in urothelial carcinomas of the upper urinary tract (2008) (63)
Profiling and classification tree applied to renal epithelial tumours (2007) (63)
Prevention of prostate cancer by androgens: experimental paradox or clinical reality. (2004) (62)
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer (2016) (62)
Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial. (2011) (61)
Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: genomics towards personalized medicine (2012) (61)
Accuracy of Magnetic Resonance Imaging/Ultrasound Fusion Targeted Biopsies to Diagnose Clinically Significant Prostate Cancer in Enlarged Compared to Smaller Prostates. (2015) (60)
PCAP is the major known prostate cancer predisposing locus in families from south and west Europe (2001) (58)
The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy (2013) (57)
Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival (2014) (56)
Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives. (2002) (55)
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. (2007) (55)
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels (2011) (55)
A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis (2008) (55)
Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract (2009) (55)
UPREGULATION OF ENDOTHELIN 1 AND ITS PRECURSOR BY IL-1β, TNF-α, and TGF-β IN THE PC3 HUMAN PROSTATE CANCER CELL LINE (1999) (55)
PGE2 and LTB4 tissue levels in benign and cancerous prostates. (2008) (55)
Microsatellite instability in urothelial carcinoma of the upper urinary tract. (2003) (53)
Androgens are not a direct requirement for the proliferation of human prostatic epithelium in vitro (1997) (52)
Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives (2000) (52)
Contemporary role of lymph node dissection at the time of radical nephroureterectomy for upper tract urothelial carcinoma (2017) (52)
Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. (2011) (51)
The influence of obesity-related factors in the etiology of renal cell carcinoma—A mendelian randomization study (2019) (51)
Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas (2010) (51)
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors (2004) (50)
Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study. (1996) (49)
Variations in arterial blood supply and the risk of hemorrhage during percutaneous treatment of lesions of the pelviureteral junction obstruction: report of a case of testicular artery arising from an inferior polar renal artery (2005) (49)
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing. (2021) (48)
Recurrent cytogenetic alterations of prostate carcinoma and amplification of c‐myc or epidermal growth factor receptor in subclones of immortalized pnt1 human prostate epithelial cell line (1995) (48)
Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome. (2005) (47)
Telomerase activity as a potential marker in preneoplastic bladder lesions (2000) (47)
Heterogeneity in genetic susceptibility to prostate cancer. (2001) (47)
In vivo model mimicking natural history of dog prostate cancer using DPC‐1, a new canine prostate carcinoma cell line (2001) (47)
[French ccAFU guidelines - Update 2018-2020: Prostate cancer]. (2018) (47)
Oncogene amplifications in early‐stage human prostate carcinomas (1994) (47)
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single‐centre experience (2009) (46)
Genome-wide interaction study of smoking and bladder cancer risk. (2014) (46)
Non‐invasive molecular detection of bladder cancer recurrence (2002) (46)
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (46)
FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells (1999) (45)
Segregation Analysis of Prostate Cancer in France: Evidence for Autosomal Dominant Inheritance and Residual Brother‐brother Dependence (2003) (45)
Prevalence, management, and prognosis of bladder cancer in patients with neurogenic bladder: A systematic review (2018) (45)
Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy (2015) (44)
Assessment of microsatellite instability in urine in the detection of transitional‐cell carcinoma of the bladder (1998) (44)
Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy (2015) (44)
Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene (2004) (43)
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion (2003) (43)
[French ccAFU guidelines - Update 2018-2020: Prostate cancer]. (2018) (42)
[CCAFU french national guidelines 2016-2018 on prostate cancer]. (2016) (41)
Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract (2012) (41)
Expression of estrogen related proteins in hormone refractory prostate cancer: association with tumor progression. (2010) (40)
Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy (2013) (39)
BCAR1 expression in prostate cancer: Association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining (2007) (39)
Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer. (1999) (38)
Effect of Genetic Variability within 8q24 on Aggressiveness Patterns at Diagnosis and Familial Status of Prostate Cancer (2008) (38)
Is there a contemporary role for percutaneous needle biopsy in the era of small renal masses? (2012) (38)
Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder. (1999) (38)
Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. (2011) (37)
Hereditary Prostate Cancer and Other Genetic Predispositions to Prostate Cancer (1998) (37)
Quantitative RT‐PCR analysis of PSA and prostate‐specific membrane antigen mRNA to detect circulating tumor cells improves recurrence‐free survival nomogram prediction after radical prostatectomy (2012) (36)
Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. (2017) (35)
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations (2018) (35)
Genetic susceptibility to prostate cancer (2005) (35)
Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa) (2008) (35)
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens (2001) (35)
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations (2019) (35)
Phenol Sulfotransferase SULT1A1*2 Allele and Enhanced Risk of Upper Urinary Tract Urothelial Cell Carcinoma (2007) (35)
Microsatellite instability and transitional cell carcinoma of the upper urinary tract (2005) (35)
Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (35)
An experimental model of bulbar urethral stricture in rabbits using endoscopic radiofrequency coagulation. (1999) (35)
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer (2020) (34)
Association between estrogen and androgen receptor genes and prostate cancer risk. (2009) (34)
Night work and prostate cancer risk: results from the EPICAP Study (2018) (34)
Impact of prostate cancer screening on health-related quality of life in at-risk families. (2002) (34)
Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. (1995) (34)
Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk. (2003) (34)
Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. (2016) (33)
The Role of Laser‐Induced Autofluorescence Spectroscopy in Bladder Tumor Detection: Dependence on the Excitation Wavelength (1998) (33)
Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer. (2015) (33)
Large-scale fine mapping of the HNF1B locus and prostate cancer risk. (2011) (33)
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (32)
Cancer de la prostate. Épidémiologie. Facteurs de risques. Anatomopathologie (2004) (32)
Identification of endothelin receptors in normal and hyperplasic human prostate tissues (1996) (31)
Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer (1999) (31)
[French ccAFU guidelines - update 2020-2022: prostate cancer]. (2020) (31)
Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line. (1999) (31)
Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate (2018) (31)
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of non-aggressive disease (2018) (31)
Worry and attitude of men in at‐risk families for prostate cancer about genetic susceptibility and genetic testing (2002) (31)
Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. (2003) (30)
Genetic variability in 8q24 confers susceptibility to urothelial carcinoma of the upper urinary tract and is linked with patterns of disease aggressiveness at diagnosis. (2012) (30)
Constitutive expression of FGF2/bFGF in non‐tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype (1997) (30)
Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. (2012) (29)
Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression Score. (2015) (29)
Pharmacological and molecular evidence for the expression of the two steroid 5α‐reductase isozymes in normal and hyperplastic human prostatic cells in culture (1997) (29)
68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact (2020) (28)
Differential expression of the semaphorin 3A pathway in prostatic cancer (2009) (28)
HOXB13 is a sensitive and specific marker of prostate cells, useful in distinguishing between carcinomas of prostatic and urothelial origin (2013) (28)
CHC1‐L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer (2002) (28)
Current role of image‐guided robotic radiosurgery (Cyberknife®) for prostate cancer treatment (2013) (27)
Anatomical bases of percutaneous surgery for calculi in horseshoe kidney (2005) (27)
Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur (2012) (27)
Ultraviolet laser-induced autofluorescence distinction between malignant and normal urothelial cells and tissues. (1996) (27)
IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. (1993) (27)
Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer. (2004) (27)
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2014) (27)
Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate. (2002) (26)
Differential expression of 37 selected genes in hormone‐refractory prostate cancer using quantitative taqman real‐time RT‐PCR (2005) (26)
Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. (2016) (26)
Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract. (2008) (26)
A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry. (2020) (26)
Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study. (2013) (25)
Metastin (KISS-1) and metastin-coupled receptor (GPR54) expression in transitional cell carcinoma of the bladder. (2007) (25)
The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study. (2015) (25)
Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer (2005) (25)
Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. (2008) (25)
Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men. (2019) (25)
A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer. (2016) (25)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
A microdissection approach to detect molecular markers during progression of prostate cancer. (1995) (24)
Tissue expression of IL16 in prostate cancer and its association with recurrence after radical prostatectomy (2010) (24)
Differential chromosome allelic imbalance in the progression of human prostate cancer. (1996) (24)
Refining the Prostate Cancer Genetic Association within the JAZF1 Gene on Chromosome 7p15.2 (2010) (24)
African‐specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer (2020) (23)
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (23)
Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry. (2011) (23)
Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers (2015) (22)
Laparoscopic fibrin glue ureteral anastomosis: experimental study in the porcine model. (1996) (22)
Allelic losses in localized prostate cancer: association with prognostic factors. (2003) (22)
Outcome after radical prostatectomy in young men with or without a family history of prostate cancer. (2006) (22)
No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer (2001) (22)
[Genetics and urology]. (2000) (21)
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019? (2019) (21)
Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI. (2020) (21)
Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours (2013) (21)
Thérapie de sauvetage par implantation d’un sphincter artificiel urinaire après échec de bandelette Advance™ pour incontinence urinaire après prostatectomie : une expérience monocentrique ☆ (2012) (21)
The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. (2014) (21)
Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test. (2011) (21)
Molecular analysis of the FHIT gene in human prostate cancer (1998) (21)
Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone. (2015) (21)
Tumour-associated trypsin inhibitor and renal cell carcinoma. (1995) (20)
Caractérisation immunohistochimique des principaux types histologiques de tumeurs rénales épithéliales étudiées par tissue-arrays sur une série de 310 cas (2004) (20)
Expression in bladder transitional cell carcinoma by real‐time quantitative reverse transcription polymerase chain reaction array of 65 genes at the tumor suppressor locus 9q34.1‐2: Identification of 5 candidates tumor suppressor genes (2004) (20)
Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience (2009) (20)
Differential Expression of Genes Related to Androgen and Estrogen Metabolism in Hereditary versus Sporadic Prostate Cancer (2008) (20)
TVT SECUR single-incision sling after 5 years of follow-up: the promises made and the promises broken. (2012) (19)
DNA microarrays in clinical practice: past, present, and future (2003) (19)
Hereditary‐like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin‐based chemotherapy after radical nephroureterectomy than do sporadic tumours (2014) (19)
Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours (1997) (19)
Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study (2021) (19)
Facteurs de risque génétiques pour le cancer de la prostate (2004) (19)
[Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases]. (2004) (19)
Sex specific associations in genome wide association analysis of renal cell carcinoma (2019) (19)
Comparison of semi-automated and manual methods to measure the volume of prostate cancer on magnetic resonance imaging. (2017) (18)
Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression. (2014) (18)
Malnourishment in bladder cancer and the role of immunonutrition at the time of cystectomy: an overview for urologists (2014) (18)
[Prostate cancer. Treatment]. (2004) (18)
Relationship between non-suspicious MRI and insignificant prostate cancer: results from a monocentric study (2016) (18)
Evolution of the landscape of surgical management of prostate cancer in France: the case of radical prostatectomy. (2012) (18)
Percutaneous extra-anatomic nephrovesical diversion: preliminary report. (1993) (18)
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy (2018) (18)
Cross‐cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy (2009) (17)
Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures. (2012) (17)
Inappropriate treatment of prostate cancer caused by heterophilic antibody interference (2009) (17)
BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy (2012) (17)
Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study. (2015) (16)
[Impact of the COVID-19 pandemic on surgical activity within academic urological departments in Paris]. (2020) (16)
Regulation of prostate growth (2001) (16)
International cancer seminars: a focus on kidney cancer. (2016) (16)
Two‐photon optical imaging, spectral and fluorescence lifetime analysis to discriminate urothelial carcinoma grades (2018) (16)
Recommandations françaises du Comité de cancérologie de l’AFU – actualisation 2020–2022 : cancer de la prostate (2020) (16)
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus (2017) (16)
Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up (2021) (16)
TEP/TDM et récidive biologique d’adénocarcinome prostatique : apport du 68Ga-PSMA-11 lorsque la 18F-fluorocholine n’est pas contributive (2017) (16)
Prostate cancer genetics. (2005) (16)
A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting (2013) (16)
CGA gene (Coding for the α subunit of glycoprotein hormones) overexpression in ERα-positive prostate tumors (2002) (15)
Prospective, multidimensional evaluation of sexual disorders in men after laser photovaporization of the prostate. (2013) (15)
Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP (2014) (15)
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry (2012) (15)
Thermal radiofrequency induced porcine ureteral stricture: a convenient endourologic model. (1999) (15)
Impact of adoption of a decision algorithm including PCA3 for repeat biopsy on the costs for prostate cancer diagnosis in France (2013) (15)
Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer. (2020) (15)
Accuracy of the routine detection of mutation in mismatch repair genes in patients with susceptibility to hereditary upper urinary tract transitional cell carcinoma (2005) (15)
Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer. (1996) (14)
Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies) (2014) (14)
Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG (2012) (14)
Apparent diffusion coefficient value is a strong predictor of unsuspected aggressiveness of prostate cancer before radical prostatectomy (2016) (14)
Different subtypes of carcinoma in situ of the bladder do not have a different prognosis (2013) (14)
The BRCA2 gene is not relevant to sporadic prostate tumours (1996) (14)
HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin (2016) (14)
Impact de la pandémie de COVID-19 sur l’activité chirurgicale au sein des services d’urologie de l’Assistance Publique – Hôpitaux de Paris (2020) (14)
A New Prostatic Stent for the Treatment of Benign Prostatic Hyperplasia in High–Risk Patients (2000) (13)
[Cystectomy with preservation of the prostate in the treatment of bladder tumours: anatomical basis, surgical techniques, indications and results]. (2003) (13)
Outcomes of non-self-expandable metal prostheses in strictured human ureter: suggestions for future developments. (1993) (13)
Human prostatic cells in culture: Different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates (1996) (13)
Noninvasive detection of genetic instability in cells from prostatic secretion as a marker of prostate cancer. (2001) (13)
Analysis of bladder cancer subtypes in neurogenic bladder tumors. (2018) (13)
[Prostate cancer. Epidemiology. Risk factors. Pathology]. (2004) (13)
Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach. (2004) (13)
Circadian genes and risk of prostate cancer: Findings from the EPICAP study (2019) (13)
Screening, diagnosis and monitoring of sarcopenia: When to use which tool? (2022) (12)
Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer. (2016) (12)
[Salvage therapy with artificial urinary sphincter after Advance™ male sling failure for post-prostatectomy incontinence: a first clinical experience]. (2012) (12)
A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer. (2002) (12)
Association between androgen receptor gene CAG trinucleotide repeat length and testicular histology in older men. (2006) (12)
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy (2014) (12)
Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways (2011) (12)
Charlson score as a single pertinent criterion to select candidates for active surveillance among patients with small renal masses (2014) (12)
A comparative study of peptide-based imaging agents [68Ga]Ga-PSMA-11, [68Ga]Ga-AMBA, [68Ga]Ga-NODAGA-RGD and [68Ga]Ga-DOTA-NT-20.3 in preclinical prostate tumour models. (2020) (12)
MP67-05 FIRST ROUND OF TRANS-RECTAL TARGETED BIOPSIES WITH MAGNETIC RESONANCE IMAGING/ULTRASOUND-FUSION IMAGES VERSUS CONVENTIONAL ULTRASOUND-GUIDED BIOPSIES FOR THE DIAGNOSIS OF LOCALISED PROSTATE CANCER. (2014) (12)
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry (2022) (12)
Etude PROGENE, projet français d'analyse génétique du cancer de la prostate familial : recrutement et analyse (1996) (12)
Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study (2020) (11)
CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors. (2002) (11)
Facteurs de croissance et tumeurs de la prostate (1997) (11)
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (11)
Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake. (2013) (11)
Anatomic basis of laparoscopic surgery in the male pelvis (2005) (11)
Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients (2015) (11)
Marital status and prostate cancer incidence: a pooled analysis of 12 case–control studies from the PRACTICAL consortium (2021) (11)
Aurora-A/STK-15 Is Differentially Expressed in the Micropapillary Variant of Bladder Cancer (2009) (11)
[Xanthogranulomatous pyelonephritis. Value of magnetic resonance imaging]. (1989) (11)
A report of unusual crossed fused renal ectopia and minimal invasive management of calculi (2007) (11)
[Genetic aspects in cancers of the prostate]. (1996) (11)
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer (2021) (11)
Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway (2017) (11)
From active surveillance to the concept of secondary prevention. (2011) (11)
Adenovirus-mediated gene transfer in dog prostate: a preclinical study of a relevant model system for gene therapy of human prostatic cancer (1999) (11)
The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor (2020) (11)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) (2012) (11)
Séquelles fonctionnelles de la prise en charge du cancer de prostate localisé (2010) (11)
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer (2019) (11)
Dépistage du cancer de la prostate : étude de 600 cas (1990) (10)
[Growth factors and prostatic tumors]. (1997) (10)
A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases (2020) (10)
Secondary chemoprevention of localized prostate cancer by short-term androgen deprivation to select indolent tumors suitable for active surveillance: a prospective pilot phase II study (2014) (10)
[Hemostasis technics in partial nephrectomy]. (1996) (10)
Clinical characteristics and pathologic findings in patients eligible for active surveillance who underwent radical prostatectomy. (2012) (10)
Evaluation of optimal stent size after antegrade endopyelotomy: an experimental study in the porcine model. (1997) (10)
Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma. (2014) (10)
[Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43]. (1999) (10)
[Leiomyoma of the urinary excretory tract]. (1989) (10)
Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinoma. (2010) (10)
[Epidemiology of familial prostatic cancer: 4-year assessment of French studies]. (1999) (10)
Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study (2018) (10)
Epithelial phenotypes in the developing human prostate. (2006) (9)
Prostate-sparing cystectomy for bladder cancer: a step toward a dead-end. (2010) (9)
The integrin signalling adaptor p130CAS is also a key player in prostate cancer (2011) (9)
Tumeur urothéliale primitive du haut appareil urinaire et seconde localisation ultérieure intravésicale (2009) (9)
No evidence for fibroblast growth factor receptor 3 (FGFR‐3) R248C/S249C mutations in human prostate cancer (2000) (9)
Immediate Nephroureterectomy or After Attempting Conservative Treatment, on Elective Indications, for Upper Urinary Tract Urothelial Carcinoma: Comparison of the Pathology Reports on a Retrospective Monocentric Study. (2015) (9)
Résultats carcinologiques et fonctionnels de la prostatectomie totale dans les cancers de la prostate T3 (2009) (9)
Endourological treatment of lumbar and iliac ureteral stones. A comparative study of 49 cases. (1994) (9)
gsSKAT: Rapid gene set analysis and multiple testing correction for rare‐variant association studies using weighted linear kernels (2017) (9)
Urology surgical activity and COVID‐19: risk assessment at the epidemic peak: a Parisian multicentre experience (2020) (9)
[Culturing of normal and tumor cells of the human prostate]. (1989) (8)
Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study (2011) (8)
[Primary upper urinary tract tumors and subsequent location in the bladder]. (2009) (8)
Limiting radiation exposure during prostatic arteries embolization: influence of patient characteristics, anatomical conditions, and technical factors (2021) (8)
Impact de l'obésité sur le PSA lors du dépistage du cancer de la prostate (2007) (8)
Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer (2005) (8)
Utilité clinique de la tomographie par émission de positons dans le cancer de la prostate (2007) (8)
[The value of MRI in ruptures of the corpus cavernosum]. (1993) (8)
Impact of Genotyping on Outcome of Prostatic Biopsies: A Multicenter Prospective Study (2011) (8)
Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience. (2011) (8)
Low penetrance genetic susceptibility to kidney cancer (2006) (8)
Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma (2013) (8)
Pathologic Reassessment of Prostate Cancer Surgical Specimens Before Molecular Retrospective Studies (2010) (8)
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study. (2015) (8)
[PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of 68Ga-PSMA-11 when 18F-fluorocholine is non-contributive]. (2017) (7)
Gene transfer to urethral strictures in rabbits: a preliminary report (2000) (7)
[Urinary and sexual disorders following localised prostate cancer management]. (2010) (7)
Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage (2009) (7)
Distinct androgen 5 alpha-reduction pathways in cultured fibroblasts and immortalized epithelial cells from normal human adult prostate. (1994) (7)
Endoscopic Surveillance of Self-Expandable Metal Prostheses in Recurrent Urethral Strictures (1992) (7)
Ureteral gene transfer to porcine induced strictures using endourologic delivery of an adenoviral vector. (1999) (7)
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24 (2021) (7)
[Clinical usefulness of positron emission tomography in prostate cancer]. (2007) (7)
Olfactory detection of prostate cancer by dogs (2012) (7)
Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families (2012) (7)
Comparison of 18F-sodium fluoride PET/CT, 18F-fluorocholine PET/CT and diffusion-weighted MRI for the detection of bone metastases in recurrent prostate cancer: a cost-effectiveness analysis in France (2020) (7)
Étiologie et prise en charge de la dysfonction érectile chez l’insuffisant rénal chronique (2009) (7)
Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case‐Control Sequencing Studies (2016) (6)
Application of a Novel Score Test for Genetic Association Incorporating Gene-Gene Interaction Suggests Functionality for Prostate Cancer Susceptibility Regions (2011) (6)
Restaging the Biochemical Recurrence of Prostate Cancer with [68Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management (2021) (6)
Postoperative assessment of nosocomial transmission of COVID-19 after robotic surgical procedures during the pandemic (2020) (6)
Functional magnetic resonance imaging and molecular pathology at the crossroad of the management of early prostate cancer (2015) (6)
[Familial forms of cancer of the urogenital tract: clinical and genetic features]. (1996) (6)
Dilatation congénitale de la voie biliaire (1987) (6)
Paternité tardive : aspects spermatiques et génétiques (2006) (6)
Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score (2021) (6)
The Genetic Complexity of Prostate Cancer (2020) (6)
Transition zone and anterior stromal prostate cancers: Evaluation of discriminant location criteria using multiparametric fusion-guided biopsy. (2018) (6)
In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells. (2005) (6)
Genetic susceptibility to prostate cancer. (2005) (6)
Le point sur la prédisposition génétique pour le cancer de la prostate (2015) (6)
High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy. (2005) (6)
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population. (2016) (6)
Évaluation prospective du traitement de l’incontinence urinaire post-prostatectomie par injections intrasphinctériennes de cellules musculaires autologues (2011) (6)
Bayesian predictive model to assess BRCA2 mutational status according to clinical history: Early onset, metastatic phenotype or family history of breast/ovary cancer (2021) (6)
[Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy]. (2011) (6)
Double ureter and congenital diverticulum of the ureter (2005) (6)
Facteurs de croissance prostatiques et hypertrophie bénigne de la pr ostate Etat des connaissances actuelles et perspectives (1992) (5)
Common Δ2 and Δ8 RB1 variants in human breast and prostate tissues (1999) (5)
[Sexually transmitted diseases in men]. (1996) (5)
Typology of intravesical prostatic protrusions, or so-called median lobes, in middle-aged and older men (2018) (5)
12p12‐13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genes (2001) (5)
[Impact of obesity on PSA in prostate cancer screening]. (2007) (5)
[Role of endoscopy in the management of upper urinary tract tumors]. (2006) (5)
Cancer de l’urètre féminin, à propos de trois cas et revue de la littérature (2008) (5)
Prévalence et sévérité de la dysfonction érectile dans une population d'insuffisants coronariens : étude monocentrique (2008) (5)
Epithelial Phenotypes in the Developing Human Prostate (2007) (5)
Stratégies de diagnostic précoce et de prévention du cancer de la prostate (2010) (5)
576 Prediction of cancer-specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: Development of an optimized post-operative nomogram using decision curve analysis (2013) (5)
[Pharmaco and diet based prostate cancer prevention]. (2013) (5)
[Update on genetic predisposition to prostate cancer]. (2015) (4)
Pharmaco-prévention et nutri-prévention des cancers de la prostate (2013) (4)
[Prostatic growth factors and benign hypertrophy of the prostate. Current knowledge and perspectives]. (1992) (4)
Carcinomes urothéliaux de la voie excrétrice supérieure (2005) (4)
[Influence of plasmatic testosterone during natural history of prostate cancer: a review]. (2013) (4)
[Prostate cancer: Diagnosis and staging]. (2004) (4)
Differential chromosome allelic imbalance in the progression of human prostate cancer (1996) (4)
[Erectile dysfunction and renal chronic insufficiency: etiology and management]. (2009) (4)
Bladder mapping of tumour recurrence after radical nephroureterectomy for upper tract urothelial carcinoma and its influence on oncological outcomes (2019) (4)
[The treatment of metastasized kidney cancer. Current data and perspectives]. (1993) (4)
Cancer de la prostate. Traitement (2004) (4)
292 Salvage therapy with artificial urinary sphincter after advance male sling failure for post-prostatectomy incontinence: A first clinical experience (2012) (4)
Prise en charge du cancer de la prostate : analyse rétrospective de 808 hommes biopsiés en France (2013) (4)
Loss of Heterozygosity at Chromosome 16 q in Prostate Adenocarcinoma : Identification of Three Independent Regions 1 (1997) (4)
[Microsurgical creation of arteriovenous fistulas for chronic hemodialysis in children weighing less than 10 kg]. (1986) (4)
Bladder carcinomas in patients with neurogenic bladder and urinary schistosomiasis: are they the same tumors? (2022) (4)
[Hereditary forms of kidney cancer and genetic screening]. (2003) (4)
Exploration and endoscopic treatment of unilateral primary haematuria: is non-specific diffuse pyelitis a real entity? (1994) (4)
The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol (2022) (3)
[Late paternity: spermatogenetic aspects]. (2006) (3)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas (2021) (3)
[Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer]. (2009) (3)
Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men (2019) (3)
New experimental model of ureteropelvic junction obstruction allowing easy access for percutaneous surgery. (1997) (3)
Relevance of PSA-nanotest on capillary blood in organised mass screening of prostate cancer (2002) (3)
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (3)
[The role of the laser in urology]. (1995) (3)
Oncological outcomes of radical nephroureterectomy versus kidney-sparing surgery for elective treatment of clinically organ-confined upper tract urothelial carcinoma of the distal ureter. (2015) (3)
Implantation intestinale de sphincter artificiels (1992) (3)
Interprétation clinique d'une élévation du taux des PSA sanguins (2002) (3)
Effet du traitement par pegfilgrastim sur la fixation de la fluorocholine (18F) par la moelle osseuse (2012) (3)
Analyse morphométrique semi quantitative de l’histologie testiculaire au cours du vieillissement (2003) (3)
426 Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer (2012) (3)
[Strategies for early diagnosis and prevention of prostate cancer]. (2010) (3)
Genetic impact on prostate anatomical variability during ageing: role of CYP17, SRD5A2 and androgen receptor genes polymorphisms (2007) (3)
Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough? (2020) (3)
Strecker stent as ureteral stent : experimental study (1992) (3)
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology Review. (2020) (3)
Causes et facteurs prédictifs d’une hospitalisation postopératoire prolongée après urétéroscopie souple : expérience d’un centre hospitalo-universitaire (2020) (3)
Incidence of bladder cancer in neuro-urological patients in France: a nationwide study (2022) (3)
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate (2018) (3)
Common delta2 and delta8 RB1 variants in human breast and prostate tissues. (1999) (3)
Genetic variability in 13q33 and 9q34 is linked to aggressiveness patterns and a higher risk of progression of non‐muscle‐invasive bladder cancer at the time of diagnosis (2020) (2)
Imagerie de diffusion comme marqueur non invasif de l’agressivité du cancer de prostate : comparaison aux marqueurs biologiques, histologiques, immuno-histochimiques et moléculaires (2015) (2)
Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82) (2022) (2)
[The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis]. (1996) (2)
Relevance of the prostate‐specific antigen (PSA) nanotest compared to the classical PSA test in the organized mass screening of prostate cancer (2007) (2)
DNA microarrays in clinical practice: present or future? (2002) (2)
A study of the immunohistochemical profile of bladder cancer in neuro-urological patients by the French Association of Urology (2022) (2)
[Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q]. (1995) (2)
Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL (2014) (2)
[Carcinoma of Bellini's tubules]. (1995) (2)
996 EVOLUTION OF RADICAL PROSTATECTOMY PRACTICE IN FRANCE OVER A 10-YEAR PERIOD (2011) (2)
Nouveaux paradigmes et enjeux dans la prise en charge des cancers de la prostate (2017) (2)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy (2014) (2)
PSA levels in unaffected first degree relatives of prostate cancer patients are higher than in men without family history of the disease (2002) (2)
Facteur pronostiques du cancer de la prostate. Revue de la littérature et perspectives d'avenir (1994) (2)
Quantitative proteomic determination of diethylstilbestrol action on prostate cancer. (2013) (2)
Mise en évidence de la déformation toulousaine du crâne au Moyen Age (1989) (2)
316 Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy (2015) (2)
Influence de la testostérone plasmatique au cours de l’histoire naturelle du cancer de la prostate : analyse de la littérature (2013) (2)
What risk of prostate cancer led urologist to recommend prostate biopsies? (2015) (2)
Stroma-epithelium interactions in prostate (1994) (2)
Biologie moléculaire de la prostate normale et pathologique (2011) (2)
618 INFLUENCE OF OBESITY ON PSA LEVELS ON A SCREENED POPULATION (2007) (2)
Post-mortem detection of HIV, HTLV, hepatitis C viral infections to reduce the risk of contamination during anatomical cadaver dissections (1999) (2)
[Intestinal implantation of an artificial sphincter]. (1992) (2)
Involvement of polymorphisms in androgen/oestrogen regulating genes on latent and clinical prostate cancers (2003) (2)
Corrigendum to "French ccAFU guidelines-update 2020-2022: Prostate cancer" [Prog. Urol 30 (12 S) (2020), pp S136-S251]. (2021) (2)
Propriétés fonctionnelles d'une nouvelle lignée de cellules endothéliales humaines immortalisées (1995) (2)
BCAR1 EXPRESSION IN PROSTATE CANCER (2006) (2)
Genetic susceptibility to prostate cancer : Abstract (2004) (1)
[Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test]. (2017) (1)
Etude biométrique et radiologique de trois crânes «toulousains» du bas moyen âge (1990) (1)
Évaluation précoce des troubles postopératoires après photovaporisation de la prostate Greenlight™ grâce à un questionnaire dédié (2016) (1)
La génétique au coeur du débat ethique (2000) (1)
Pathological reporting of cystectomy lymph nodes: a retrospective analysis of experience in Paris (2021) (1)
[Evaluation of postoperative symptoms after Greenlight™ photovaporization of the prostate through a dedicated questionnaire]. (2016) (1)
Analyse génétique du cancer de la pr ostate familial : localisation d'un gène prédisposant au cancer de la prostate (PCaP) sur le chromosome 1q 42.2-43 (1999) (1)
[Laparoscopic treatment of vesico-ureteral reflux in the pig. Preliminary report]. (1994) (1)
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (1)
[Central venous stenoses after using a Hickman catheter in hemodialysis in children. Apropos of 4 cases]. (1989) (1)
580 IS SCREEN-DETECTED PROSTATE CANCER IN HIGH RISK FAMILIES ELIGIBLE FOR ACTIVE SURVEILLANCE? (2010) (1)
Influence du vieillessement sur la spermatogenèse: étude histologique et cytogénétique moléculaire au niveau testiculaire chez 46 sujets âgés de 29 à 102 ans (2004) (1)
COMPARISON OF PROSTATE CANCER GENE EXPRESSION BEFORE AND AFTER HORMONAL RELAPSE (2009) (1)
Rare Germline Variants Are Associated with Rapid Biochemical Recurrence After Radical Prostate Cancer Treatment: A Pan Prostate Cancer Group Study. (2022) (1)
[Renal and urinary tract disease national research program]. (2007) (1)
[Infertility and testicular seminoma]. (2007) (1)
Étude française sur le dépistage du cancer de la prostate dans les familles à risque : résultats à 8 ans dans le groupe 40–49 ans (2016) (1)
Region 2 of 8 q 24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe ( French West Indies ) (1)
PD-L1 (SP142) testing is concordant between Benchmark Ultra and Bond-III stainers (2021) (1)
500 MOLECULAR DIAGNOSIS OF LOCALIZED PROSTATE CANCER BY QUANTITATIVE METHYLATION-SPECIFIC PCR GENE PATTERNS IN URINE CELLS OBTAINED BY PROSTATE MASSAGE (2007) (1)
837 PROTEOMICS AND GENOMICS INVESTIGATIONS OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 (2011) (1)
[Transplantation of a horse-shoe kidney. Report of a case and review of the literature]. (1992) (1)
[Genetics and germinal tumors of the testis]. (2003) (1)
Additional SNPs improve the performance of a polygenic hazard score for prostate cancer (2020) (1)
En cas de première série de biopsies de prostate, les biopsies prostatiques ciblées par voie transréctale avec fusion écho/IRM ont un meilleur rendement que les biopsies standard pour la détection de cancer significatif dans les prostates > 40 mL (2014) (1)
Infertilité et séminome testiculaire (2007) (1)
Quel niveau de risque incite l’urologue à réaliser des biopsies de la prostate ? Analyse rétrospective et multicentrique française (2013) (1)
1631 EVOLUTION OF RADICAL PROSTATECTOMY PRACTICE IN FRANCE OVER A 10-YR PERIOD (2011) (1)
[Prevalence and severity of erectile dysfunction in a population with coronary insufficiency: monocentric study]. (2008) (1)
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum. (2022) (1)
Standardizing immunohistochemistry methodology for evaluation of PD-1 and PDL-1 expression in upper tract urothelial carcinoma. (2021) (1)
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019? (2019) (1)
ANAT8 Correlations radio-anatomiques du 1er compartiment des extenseurs du poignet (2005) (1)
332 A systematic review and meta-analysis of clinicopathologic factors linked with intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma (2015) (1)
Programme national de recherche sur les maladies du rein et des voies urinaires (2007) (1)
Infertilites, ambiguites sexuelles masculines & cryptorchidies (2000) (1)
Malformations de l'appareil urinaire et dysplasies kystiques des reins (2000) (1)
Formes familiales des cancers de la prostate (2005) (1)
De la surveillance active à la prévention secondaire du cancer de la prostate (2012) (1)
[Prevalence and diversity of management of prostate cancer patients classified as low risk using D'Amico group or Cancer of the Prostate Risk Assessment (CAPRA) score: A French multicenter study]. (2017) (1)
[Not Available]. (2014) (1)
UP-1.179: Cure of Post-Prostatectomy Incontinence by Transobturator Male Sling (2009) (1)
[How is prostate cancer screening perceived by men 50 to 70 years of age? Analysis based on 1,774 screened individuals]. (2007) (1)
"Vie" et mort dans le prieuré clunisien de Saint-Nicolas d'Acy : archéologie funéraire et anthropologie (1991) (1)
Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG) (2011) (1)
Functional characterization of 5p15.33 risk locus in uveal melanoma reveals rs452384 as a functional variant and NKX2.4 as an allele-specific interactor (2022) (1)
Paéopathologie d'une blessure faciale par balle observée sur un crâne nord-african: Etude Qualitative des premiers signes osseux de régénération (1995) (1)
[Functional properties of a new line of immortalized human endothelial cells]. (1995) (1)
Men with a family history of prostate cancer: does screening create anxiety? (2002) (1)
19 Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma (2014) (1)
Clinical performance of MRI & biomarkers for prostate cancer diagnosis in men at high genetic risk. (2023) (1)
Évolution du nombre de cystectomies totales en France pour tumeur infiltrante de la vessie au cours des 10 dernières années : analyse objective des données nationales du PMSI (2014) (1)
Néphrectomie par voie cœlioscopique transpéritonéale pour rein non fonctionnel (2011) (1)
Étude multicentrique sur la distribution des scores d’AMICO et CAPRA au diagnostic et sur la prise en charge des patients classés à faible risque (2014) (1)
694 CROSS-CULTURAL VALIDATION OF A PROGNOSTIC TOOL: EXAMPLE OF THE LIMITATIONS OF THE KATTAN PREOPERATIVE NOMOGRAM AS A PREDICTOR OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (1)
Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54]. (2018) (1)
775: Immunohistochemical Characterisation of the Main Histological Types of Epithelial Renal Tumours Using Tissue Micro-Arrays : A Study of 310 Cases (2004) (1)
Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry. (2023) (1)
Comment le dépistage du cancer de la prostate est-il perçu par les hommes de 50 à 70 ans ? Analyse à partir de 1774 individus dépistés (2007) (1)
Voies de carcinogenèse et histoire naturelle des tumeurs de la voie excrétrice supérieure : état de l’art pour le rapport annuel de l’Association française d’urologie (2014) (0)
[Not Available]. (2015) (0)
Traitement conservateur des tumeurs de la voie excrétrice supérieure : devons-nous pousser les indications ? (2017) (0)
[Not Available]. (2015) (0)
Dépistage du cancer de la prostate dans les familles à risque. Le nombre d’apparentés atteints et l’âge précoce de diagnostic dans la famille augmentent le risque de CaP (2017) (0)
HOXB13, un nouveau marqueur pour distinguer le carcinome de la prostate des carcinomes d’autre origine (2013) (0)
[Not Available]. (2015) (0)
L’automatisation du Gleason, la fin d’un dilemme ? (2013) (0)
La caractérisation fonctionnelle du locus de susceptibilité au cancer du rein 12p11.23 implique le gène SHARP1 (2014) (0)
Les traitements focaux : une alternative dans la prise en charge du cancer de la prostate de bas risque ? (2017) (0)
Therapie genique principes et applications en urologie (2000) (0)
Expression des membres de la voie Hedgehog dans les adénocarcinomes prostatiques primitifs et en hormono-échappement (2006) (0)
Thérapie cellulaire de l’incontinence urinaire d’effort féminine par incompétence sphinctérienne par injection intrasphinctérienne de cellules musculaires autologues : résultats à 6 ans de recul (2013) (0)
Résultat d’un traitement chirurgical de sauvetage guidé par le résultat du TEP/TDM au 68Ga-PSMA-11 pour la récidive biologique après prostatectomie radicale (2019) (0)
Déformation crânienne dite «Toulousaine». Etude anthropologique de crânes dans le plan sagittal (1992) (0)
[Not Available]. (2015) (0)
Étude de la corrélation entre le taux préopératoire de testostérone et les caractéristiques anatomopathologiques des pièces de prostatectomie radicale (2013) (0)
Développement et validation du premier nomogramme français capable de prédire la survie spécifique postopératoire après néphro-urétérectomie pour tumeur de la voie excrétrice supérieure (2012) (0)
Apport prédictif d’une signature moléculaire à la classification pronostique CAPRA des cancers de prostate avant prostatectomie radicale (2020) (0)
Suivi à moyen terme après implantation de mini-bandelette Ajust™ pour le traitement de l’incontinence urinaire féminine : efficacité, complications et facteurs pronostiques (2013) (0)
IRM multiparamétrique et biopsies ciblées : intérêt pour la détection et la caractérisation des cancers prostatiques de la zone de transition (2016) (0)
Tumeurs de vessie sur vessie neurologique en France entre 2013 et 2016 : comparaison à une population de tumeurs sur vessie non neurologique (2021) (0)
Thérapie génique du cancer de la prostate (1999) (0)
Évaluation du score CCP (Prolaris® test), et de l’expression du gène PTEN, comme marqueurs prédictifs de la récidive après prostatectomie radicale (2013) (0)
Place de l’imagerie IRM, des biopsies en fusion d’image et des nouveaux marqueurs dans la stratégie diagnostique des cancers de la prostate (2017) (0)
Influence de la taille de la prostate sur les résultats de la photovaporisation laser de prostate : étude prospective sur 192 patients (2012) (0)
Évaluation prospective de la mutation FGFR3 dans l’ADN urinaire comme marqueur de surveillance des récidives du cancer de la vessie (2014) (0)
Des chiens dressés pour une nouvelle méthode de dépistage des cancers (2010) (0)
Facteurs prédictifs et pronostics du cancer du rein à composante sarcomatoïde. Résultats d’une étude UCLA et UroCCR 45 (2018) (0)
Radiothérapie interne vectorisée par 177Lu-PSMA-617 de l’adénocarcinome prostatique métastatique résistant à la castration : à propos d’un cas et revue de la littérature (2019) (0)
Iconographies supplémentaires de l'article : Place de l’imagerie IRM, des biopsies en fusion d’image et des nouveaux marqueurs dans la stratégie diagnostique des cancers de la prostate (2017) (0)
Adopter un algorithme décisionnel tenant compte du score PCA3 lors de la répétition d’une biopsie prostatique pourrait conduire à de considérables économies en France (2012) (0)
MP2-07 A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICOPATHOLOGIC FACTORS LINKED WITH INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY TO TREAT UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
Abstract #5613: Functional analysis of the promoter of the beta-microseminoprotein gene MSMB demonstrates the importance of a single nucleotide polymorphism in prostate cancer susceptibility (2009) (0)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (0)
Laser-Induced Auto Fluorescence of Normal and Tumor Bladder Cells and Tissues (1996) (0)
Abstract No. 142 Impact of Virtual Injection Software on Radiation Exposure and Operative Time during Prostate Artery Embolization (2023) (0)
Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis (2007) (0)
331 Multicenter external validation of a post-operative nomogram for predicting the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (2015) (0)
[Genetic determinants of anatomical variants of the prostate]. (2008) (0)
Abstract 826: Large-scale genome-wide association study identifies multiple novel germline susceptibility variants associated with bladder cancer risk (2021) (0)
457: Evolution of PSA Levels in First Degree Relatives of Prostate Cancer Patients, with Baseline PSA <=1NG/ML (2004) (0)
[The management of prostate cancer: a retrospective chart review in 808 French men undergoing biopsy]. (2013) (0)
[Management of prostate cancer: The new challenges]. (2017) (0)
250 Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage during early detection of prostate cancer (2004) (0)
Irreversible electroporation for local prostate cancer: Oncological and functional outcomes (2020) (0)
Use of soluble isoforms of vascular endothelial growth factor to predict response to sunitinib in metastatic renal cell carcinomas. (2010) (0)
941 Comparative assessment of steroids serum levels in European and African-Caribbean men using gas chromatography – mass spectrometry (2012) (0)
[The Campaign Program for Prostate Integrated Research]. (2010) (0)
Reply to Giuseppe Lippi's Letter to the Editor re: Jean-Nicolas Cornu, Géraldine Cancel-Tassin, Valérie Ondet, et al. Olfactory Detection of Prostate Cancer by Dogs Sniffing Urine: A Step Forward in Early Diagnosis. Eur Urol 2011;59:197-201 (2011) (0)
527 ONCOLOGIC CONTROL AFTER RADICAL PROSTATECTOMY IN MEN WITH CLINICAL T3 PROSTATE CANCER: A SINGLE-CENTER EXPERIENCE (2009) (0)
Clonal phylogenies inferred from bulk, single cell, and spatial transcriptomic analysis of cancer (2023) (0)
900 COMPARISON OF PRE- AND POSTOPERATIVE PLASMA LEVELS OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER IMPROVES PREDICTION OF RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
Bladder Cancer FGFR 3 Mutations Indicate Better Survival in Invasive Upper Urinary Tract and Bladder Tumours (2009) (0)
FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis (2006) (0)
Evaluation of non-muscle-invasive bladder cancer recurrence using a mRNA-based urine test (Xpert® Bladder Cancer Monitor) and cytology (2019) (0)
62 Age related changes in human prostate are associated with the FGFR4 ARG388 allele (2004) (0)
1600 MID-TERM EVALUATION AND PROGNOSTIC FACTORS OF TRANSOBTURATOR RETROURETHRAL SLING FOR POST-PROSTATECTOMY INCONTINENCE (2010) (0)
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable? (2022) (0)
518 EFFECT OF FAMILY HISTORY AND GENETIC POLY- MORPHISMS ON RISK AND AGGRESSIVENESS PATTERNS OF PROSTATE CANCER (2011) (0)
Association of Rs1139971, a KAI1 polymorphism, with bone metastasis progression in prostate cancer and ganglionnary metastasis. (2013) (0)
1327: Gene Expression Profiles in Benign Prostatic Hyperplasia (2004) (0)
Diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection (2020) (0)
"Virtually Perfect" for Some but Perhaps Not for All: Launching Telemedicine in the Bronx during the COVID-19 Pandemic. Letter. (2021) (0)
653: Targeted Screening in High Risk Families: High Detection Rate and Positive Predictive Value of Increased PSA (>4NG/ML) in 2+ and Early Onset Prostate Cancer Families (2004) (0)
Secondary chemoprevention using short period (3 months) of LHRHa as an option for men with low-risk localized prostate cancer (LRPC) before active surveillance (AS). (2012) (0)
Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease (2013) (0)
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry (2012) (0)
MP7-05 PROGNOSTIC VALUE OF THE PT3 SUBCLASSIFICATION FOR UPPER TRACT UROTHELIAL CARCINOMAS OF THE RENAL PELVICALYCEAL SYSTEM (2016) (0)
830 Evidence for frequent microsatellite instability in urothelial carcinomas of the upper urinary tract (2004) (0)
Prostate cancer screening in high risk families: higher detection in first degree relatives even in families without obvious hereditary patterns (2002) (0)
2238 SINGLE NUCLEOTIDE POLYMORPHISMS ARE ASSOCIATED WITH VARIATION OF PSA LEVELS IN A CONTROL POPULATION (2012) (0)
646P Prostate cancer metastatic profiles correlate with molecular alterations (2020) (0)
[Genetic features of prostatic cancer]. (2003) (0)
A method of predicting the prognosis or diagnosis or therapeutic response of disease including prostate cancer and a device for the implementation of the PROCESS. (2008) (0)
[Urethral cancer: report of three cases and review of the literature]. (2008) (0)
907 Post-operative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with pT1-T3 N0/Nx upper tract urothelial carcinoma without metastasis (2014) (0)
ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82) (2022) (0)
389 Three-year prostate cancer screening program in high risk families: High detection associated with the number of affected relatives and early onset (2004) (0)
Penile Prosthesis Implantation and Infection: Experience with the “No Touch” Surgical Technique (2018) (0)
[Toward a new border]. (2011) (0)
866 PLACEMENT OF A TRANSOBTURATOR MALE SLING FOR POST-OPERATIVE INCONTINENCE AFTER PROSTATE SURGERY: EVALUATION AFTER A 12 MONTHS FOLLOW-UP (2009) (0)
402 IMPACT OF GENOTYPING ON OUTCOME OF PROSTATIC BIOPSY IN A CLINICAL SETTING (2011) (0)
Development and validation of a cell cycle progression signature for decentralized testing of men with prostate cancer. (2022) (0)
Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases (2015) (0)
645P Prediction of BRCA2 mutations in prostate cancer patients according early onset, metastatic phenotypes or family history of breast/ovary cancer (2020) (0)
No association between a n repeat in the promoter region of the insulin-like growth factor-1 gene and sporadic prostate and breast cancer cases (1999) (0)
166 SERUM SEX STEROIDS MEASURED IN MIDDLE-AGED FRENCH CAUCASIAN AND AFRICAN-CARIBBEAN MEN, KNOWN TO HAVE A DIFFERENT RISK OF PROSTATE CANCER, USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY (2012) (0)
[Transitional cell carcinoma of the upper urinary tract new concepts in management]. (2005) (0)
Comparison of cell cycle progression (CCP) score to two IHC markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy (2018) (0)
Title: Sex Specific Associations in Genome Wide Association Analysis of Renal Cell Carcinoma (2019) (0)
ANATOMICAL FEATURES AND DISSECTION OF THE ACCESSORY PUDENDAL ARTERIES DURING LAPAROSCOPIC RADICAL PROSTATECTOMY (2006) (0)
[Histologic forms of benign prostatic hyperplasia: focus on fibroblastic factors]. (2006) (0)
1323: Age Related Changes in Human Prostate are Associated With the FGFR4 ARG388 Allele (2004) (0)
Family history of prostate cancer and non-affected men's worry about genetic susceptibility (2002) (0)
Low PSA level possibly associated with long term risk of prostate cancer in young men, aged 40–49: Correlation with the number of affected first degree relatives in high risk families (2003) (0)
10 Metabolomics profiles of prostatic secretions from patients treated by Pygeum Africanum for low urinary tract symptoms related to benign prostatic hyperplasia (2012) (0)
Screening trends in “at-risk” families for prostate cancer (2003) (0)
261 Expression and diagnostic utility of P63 and alpha-methyl-coa-racemase (P504S) cocktail in ambiguous lesion of the prostate (2004) (0)
COMPARISON OF PRE- AND POSTOPERATIVE PLASMA LEVELS OF CIRCULATING PROSTATE DERIVED CELLS IN PATIENTS WITH LOCALIZED PROSTATE CANCER IMPROVES PREDICTION OF RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
UP-1.36: Definitive assessment of early post-operative symptoms after laser photovaporization of the prostate (PVP): validation of a dedicated questionnaire (2010) (0)
Impact of obesity in the management of kidney cancer, study URO-CCR n°87 (2022) (0)
[Natural history and prognostic factors of prostate cancer]. (1994) (0)
Precision medicine in oncology needs to integrate pharmacogenetic profiling. (2015) (0)
URETHRAL GRACILOPLASTY FOR TREATMENT OF FEMALE INTRINSIC SPHINCTER DEFICIENCY: RATIONALE FOR THE TRANSVAGINAL APPROACH (1998) (0)
Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
Urethral graciloplasty for treatment of female intrinsic sphincter deficiency: rationale for the transvaginal approach: an anatomical study. (1998) (0)
MP7-06 MULTICENTER EXTERNAL VALIDATION OF A POST-OPERATIVE NOMOGRAM FOR PREDICTING THE RISK OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR UPPER TRACT UROTHELIAL CARCINOMA (2015) (0)
417 GENETIC VARIABILITY WITHIN 8Q24 CONFERS ENHANCED RISK OF UROTHELIAL CELL CARCINOMA OF THE UPPER URINARY TRACT (2010) (0)
Establishment of permanent human endothelial cells achieved by transfection with SV40 large T antigen that retain typical phenotypical and functional characteristics (2007) (0)
143 EFFECT OF FAMILY HISTORY AND GENETIC POLYMORPHISMS ON RISK AND AGGRESSIVENESS OF PROSTATE CANCER (2011) (0)
91 HIGH ACTIVITY POLYMORPHISM WITHIN DIHYDROTESTOSTERONE SYNTHESIS ENHANCES AGGRESSIVENESS OF ADVANCED PROSTATE CANCER FOR PATIENTS CARRYING THE 8Q24 PROSTATE CANCER SUSCEPTIBILITY GENOTYPES (2010) (0)
[Active surveillance for the secondary prevention of prostate cancer]. (2012) (0)
Original article High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy (2005) (0)
MP35-17 COMPARISON OF CELL CYCLE PROGRESSION (CCP) SCORE TO TWO IHC MARKERS (PTEN AND KI-67) FOR PREDICTING OUTCOME IN PROSTATE CANCER AFTER RADICAL PROSTATECTOMY. (2018) (0)
699 TISSULAR BIOMARKERS ASSOCIATED WITH SURVIVAL AFTER PROSTATE CANCER HORMONAL RELAPSE (2009) (0)
Can prostate biopsy be avoided in all patients with negative MRI? Results of a multicentric study (2022) (0)
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488]. (2023) (0)
308 Effect of genetic polymorphisms on susceptibility and aggressiveness of clear cell renal cell carcinoma (2012) (0)
Evaluation of prostate cancer tissue samples quality taken by the surgeon for molecular biology during radical prostatectomy (2003) (0)
814 IMPORTANCE OF ALLELIC INSTABILITY OF URINARY MICROSATELLITES MARKERS FOR CONSERVATIVE MANAGEMENT OF UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA (2010) (0)
Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of heterogeneity on genomic signature scoring (2023) (0)
PD35-06 POST-OPERATIVE NOMOGRAM TO PREDICT CANCER-SPECIFIC SURVIVAL AFTER RADICAL NEPHROURETERECTOMY IN PATIENTS WITH PT1-T3 N0/NX UPPER TRACT UROTHELIAL CARCINOMA WITHOUT METASTASIS (2014) (0)
2159 THE USE OF CANINES FOR PROSTATE CANCER DETECTION: TOWARDS A NON-INVASIVE ALTERNATIVE SCREENING TOOL (2010) (0)
POD-01.06: Monocentric Study of Feasibility and Safety of Intra-Sphincter Injections of Autologous Progenitor Muscular Cells in Patients with Urinary Incontinence Due To Sphincter Failure Following Radical Prostatectomy (2009) (0)
Chain Reaction Assays by Real-Time Quantitative Reverse Transcription-Polymerase Progesterone Receptor Expression in Human Prostate Cancer ) , and β ER and α ER Evaluation of Androgen , Estrogen ( Updated (2001) (0)
808 Prognostic value of the pT3 subclassification for upper tract urothelial carcinomas of the renal pelvicalyceal system (2016) (0)
6 Single nucleotide polymorphisms in genes regulating steroid hormones metabolism are independently associated with increased prostate volume in men with prostate cancer (2012) (0)
129Reconsidering familial status of prostate cancer in sporadic and in 2 cases families, after systematic PSA based screening in first degree relatives (2005) (0)
2036 IMPACT OF GENOTYPING ON OUTCOME OF PROSTATIC BIOPSIES ON A CLINICAL SETTING (2011) (0)
MP-14.16: Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection (2007) (0)
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (0)
669 EXPRESSION OF ESTROGEN RELATED PROTEINS IN HORMONE-REFRACTORY PROSTATE CANCER: ASSOCIATION WITH TUMOUR PROGRESSION (2010) (0)
DESCRIPTION OF THE SURGICAL ANATOMY OF THE FASCIAS SURROUNDING THE PROSTATE DURING LAPAROSCOPIC RADICAL PROSTATECTOMY (2006) (0)
MP60-17 PREDICTIVE CONTRIBUTION OF A MOLECULAR SIGNATURE TO THE CAPRA PROGNOSTIC CLASSIFICATION OF PROSTATE CANCERS BEFORE RADICAL PROSTATECTOMY (2021) (0)
MP-01.13: Actual medical management of LUTS/BPH across Europe beyond official clinical guidelines: a wide population study (2010) (0)
752 GENETIC VARIABILITY WITHIN 8Q24 IS ASSOCIATED WITH AGGRESSIVENESS OF ADVANCED PROSTATE CANCER SUITABLE FOR HORMONOTHERAPY (2010) (0)
23 DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target (2006) (0)
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer (2016) (0)
C-ERB-B2, AURORA-A, MIB-1 AND P53 HAVE PREDICTIVE VALUE FOR VASCULAR INVASION AND RELAPSE IN UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMAS (2008) (0)
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum. (2022) (0)
PD10-10 FOXP3 EXPRESSION SERVES AS A MARKER OF SQUAMOUS CELL DIFFERENTIATION AND AGGRESSIVE PATHOLOGY OF UROTHELIAL CARCINOMAS IN NEUROGENIC PATIENTS (2015) (0)
Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (0)
Zonal anatomy of the prostate using magnetic resonance imaging, morphometrics, and radiomic features: impact of age-related changes. (2021) (0)
Tissue microarray analysis of the diagnostic value of p53, Ki-67, CK 5/6, Cox-2 and STAG2 expression in urothelial carcinomas of neurogenic bladder (2017) (0)
A EIGHT‐YEAR SCREENING PROGRAM IN HIGH RISK FAMILIES. NUMBER OF AFFECTED RELATIVES AND EARLY ONSET ARE ASSOCIATED WITH A HIGH RISK DETECTION.: MP33‐04 (2017) (0)
PO-520 Comprehensive molecular classification of localised prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease (2018) (0)
[Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology]. (2014) (0)
606Five-year prostate cancer screening program in high risk families: Results in young first degrees relatives aged 40–49 (2005) (0)
853 PROTEOMIC INVESTIGATION OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 BY 2D-DIFFERENCE GEL ELECTROPHORESIS AND MASS SPECTROMETRY (2010) (0)
MP34-01 PREVALENCE AND DIVERSITY OF MANAGEMENT OF PROSTATE CANCER PATIENTS CLASSIFIED AS LOW RISK USING D’AMICO GROUP OR CANCER OF THE PROSTATE RISK ASSESSMENT (CAPRA) SCORE: A FRENCH MULTICENTER STUDY (2018) (0)
Irreversible Electroporation (IRE) for Prostate Cancer (2021) (0)
907Survey of androgen deprivation therapy habit for prostate cancer: Results of a french study conducted with 257 urologists (2005) (0)
550 Cancer-specific survival after nephroureterectomy for upper urinary tract urothelial carcinoma: External validation of a predictive nomogram using a French collaborative national database (2012) (0)
Facteurs de risque génétiquesle cancer de la prostate (2004) (0)
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21 (2016) (0)
[Genetic features of urothelial carcinoma of the bladder and the upper urinary tract]. (2003) (0)
CROSS-CULTURAL VALIDATION OF A PROGNOSTIC TOOL : EXAMPLE OF THE LIMITATIONS OF THE KATTAN PREOPERATIVE NOMOGRAM AS A PREDICTOR OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY (2009) (0)
Abstract 3863: Fine mapping and comprehensive resequencing analysis of a region of chromosome 11q13 reveals multiple independent loci associated with prostate cancer (2010) (0)
Molecular phenotypes in DNA repair deficiency correlate with specific clinical outcomes subtypes and genetic background (2019) (0)
Évaluation du risque de récidive des cancers de la vessie non infiltrant le muscle par le test Xpert® Bladder Cancer Monitor à partir d’arn urinaire (2018) (0)
Correlation of genetic and cytogenetic alterations in pathological aggressiveness urothelial carcinoma of the bladder: Performance of BCA-1, a mini-array comparative genomic hybridisation-based test (2018) (0)
VITAMIN D RECEPTOR POLYMORPHISMS AND PROSTATE CANCER RISK IN AN EUROPEAN POPULATION (1999) (0)
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer (2021) (0)
Function and Aggressive Disease The 19 q 12 Bladder Cancer GWAS Signal : Association with Cyclin E Updated (2014) (0)
[Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma]. (2018) (0)
44 COMPARISON OF ONCOLOGIC OUTCOMES OBTAINED AFTER OPEN OR LAPAROSCOPIC NEPHROURETE-RECTOMY FOR THE TREATMENT OF UPPER URINARY TRACT UROTHELIAL CELL CARCINOMAS (UUT-UCC): A MULTI-INSTITUTIONAL STUDY (2011) (0)
Prostate cancer screening in high risk families: Should PSA testing be performed yearly in first degree relatives with baseline PSA ≤ 1ng/ml? (2004) (0)
2110 PROSPECTIVE, MULTIDIMENSIONAL EVALUATION OF SEXUAL DISORDERS IN MEN AFTER LASER PHOTOVAPORIZATION OF THE PROSTATE BY GREENLIGHT HPS (2011) (0)
405 PROGNOSTIC RELEVANCE OF BCAR1 EXPRESSION IN PROSTATE CANCER (2011) (0)
QUANTITATIVE AND QUALITATIVE MULTIMODAL OPTICAL ANALYSIS TO DISCRIMINATE UROTHELIAL CARCINOMA GRADES: MP54‐18 (2018) (0)
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations (2018) (0)
Quantitative and qualitative multimodal optical analysis to discriminate urothelial carcinoma grades (2018) (0)
[Detection of cancer of the prostate. A study of 600 cases]. (1990) (0)
[Hereditary prostate cancer]. (2004) (0)
[Comparison of biomechanical properties of the vaginal fixation in bladder neck suspensions according to the Burch technique and a percutaneous technique]. (1999) (0)
907 Single nucleotide polymorphisms are associated with variation of PSA levels in a control population (2012) (0)
Diagnosis and prognosis of prostatic cancer, comprises analysis of specific cell markers, antigens and loss of chromosomal alleles, also used for optimizing treatment (2000) (0)
1192 PROTEOMIC INVESTIGATION OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 BY 2D-DIFFERENCE GEL ELECTROPHORESIS AND MASS SPECTROMETRY (2010) (0)
Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350]. (2020) (0)
812 GENETIC VARIABILITY WITHIN 8Q24 CONFERS ENHANCED RISK OF UROTHELIAL CELL CARCINOMA OF THE UPPER URINARY TRACT (2010) (0)
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus (2017) (0)
Frequency of allelic imbalance in prostate cancer is significantly associated with clinical and biological features (2002) (0)
[Prognostic factors in prostate cancer. Review of the literature and future perspectives]. (1994) (0)
Association du rs1139971, polymorphisme du gène KAI1, à la progression métastatique osseuse dans le cancer de prostate mais pas à la progression métastatique ganglionnaire (2013) (0)
DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries (2022) (0)
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (0)
898 IS IL-16 A PREDICTIVE MARKER OF BIOLOGIC RELAPSE IN PROSTATE CANCER? (2009) (0)
Young-onset kidney tumors: Clinico-pathological features and subset examination of their genome-wide somatic mutations. (2015) (0)
896 Mid-term follow-up after Ajust™ single incision sling implantation for women stress urinary incontinence: Efficacy, complications and prognostic factors (2013) (0)
[Focal therapies: An alternative option for low-risk prostate cancer management?] (2017) (0)
361 A COMPARATIVE ANALYSIS OF THE BEHAVIOUR OF UROTHELIAL CARCINOMA WITH RESPECT TO ANATOMICAL LOCATION (2007) (0)
Clinical value of the integration of Prostate Health Index (PHI) in multiparametric MRI-based diagnostic strategies to detect clinically-significant prostate cancer. Results from the French prospective multicenter PHI-1 study (2020) (0)
[Not Available]. (2015) (0)
1619: Plasma Estrogens in Newly Diagnosed Patients for Prostate Cancer (2007) (0)
[Role of prostate MRI, TRUS fusion biopsies and new markers in the diagnostic strategy of prostate cancer]. (2017) (0)
[High-risk clinically localised prostate cancer]. (2010) (0)
Selective cytotoxicity of a replication-selective adenovirus, dl 118, for prostatic cancer cell lines in vitro (2002) (0)
Microsurgical creation and follow up angioaccesses for chronic hemodialysis in children weighing under 10 kg (1988) (0)
702 TISSULAR BIOMARKERS ASSOCIATED WITH THE TIME TO HORMONAL RELAPSE IN PROSTATE CANCER (2009) (0)
1 Title : Post-hoc Analysis for Detecting Individual Rare Variant Risk Associations using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies Running Title : Bayesian Probit Rare Variant Analysis (2017) (0)
PROSTATE CANCER SCREENING IN HIGH RISK FAMILIES. A EIGHT‐YEAR PROSPECTIVE PROGRAM IN YOUNG FIRST DEGREE RELATIVES AGED 40‐49.: PD07‐11 (2017) (0)
Sex specific associations in genome wide association analysis of renal cell carcinoma (2019) (0)
[Causes and predictive factors of prolonged length of hospital stay after flexible ureteroscopy: Experience of a large volume institution]. (2020) (0)
284: Molecular Diagnosis of Localized Prostate Cancer by Quantitative Methylation-Specific PCR Gene Patterns in Urine Cells Obtained by Prostate Massage (2007) (0)
[Developing strategies for active surveillance]. (2010) (0)
1056 Detection of FGFR3 mutations from urine sediment DNA to predict the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (2015) (0)
Effet biologique du sérum humain recueilli avant et après une administration par voie orale de Pygeum africanum, sur diverses cultures de cellules bénignes de la prostate (2012) (0)
792 COMPARISON OF PROSTATE CANCER GENE EXPRESSION BEFORE AND AFTER HORMONAL RELAPSE (2009) (0)
624 PROTEOMICS AND GENOMICS INVESTIGATIONS OF DIETHYLSTILBESTROL ACTION ON A PROSTATE CANCER CELL LINE 22RV1 (2011) (0)
Impact de l’obésité dans la prise en charge du cancer du rein, étude URO-CCR N°87 (2021) (0)
Intérêt pronostique de l’expression de PD-1/PD-L1 dans les tumeurs de la voie excrétrice urinaire supérieure (2018) (0)
[Not Available]. (2015) (0)
Comparaison des performances diagnostiques du Prostate Health Index (PHI) et du Prostate Cancer Antigen 3 (PCA-3) pour le dépistage du cancer de la prostate (2014) (0)
Iconographies supplémentaires de l'article : Pharmaco-prévention et nutri-prévention des cancers de la prostate (2015) (0)
Influence de l’obésité sur le type histologique des tumeurs rénales opérées, étude URO-CCR N°69 (2021) (0)
Le genome humain (2000) (0)
Facteurs génétiques déterminant les variations anatomiques de la prostate (2008) (0)
Autoévaluations de l'article : Biologie moléculaire de la prostate normale et pathologique (2011) (0)
Une revue systématique des polymorphismes simples pour un nucléotide associés au cancer de la prostate (2012) (0)
Résultats périopératoires et oncologiques de la néphro-urétérectomie totale par voie laparoscopique pure versus robot assistée pour le traitement des tumeurs de la voie excrétrice urinaire supérieure (2015) (0)
[Not Available]. (2015) (0)
Carcinome renal a cellules claires : recherche protéomique de biomarqueurs par technique iTRAQ ® (2012) (0)
Évaluation du risque de contamination par le coronavirus après chirurgie robotique durant la pandémie COVID-19 (2020) (0)
Facteurs histologiques associés au pronostic oncologique après prostatectomie robot-assistée (2015) (0)
Intérêt du dosage sérique du TPA (tissue polypeptide antigen) dans les tumeurs de la vessie (1993) (0)
Impact pronostique de l’expression de pd-1 et pd-l1 pour les tumeurs de la voie excrétrice supérieure (2022) (0)
Néphro-urétérectomie d’emblée ou après tentative de traitement conservateur dans les tumeurs de la voie excrétrice supérieure : comparaison des résultats anatomopathologiques (2013) (0)
Les marqueurs biologiques pronostiques du cancer de la prostate (1994) (0)
Formes histologiques des hypertrophies bénignes de la prostate (HBP) : focus sur les facteurs fibroblastiques (2006) (0)
Amélioration de l’efficacité de la photothérapie dynamique de prostate au wst11 par une immunothérapie ciblant le récepteur csf1r : étude préclinique (2018) (0)
Cancers de la prostate cliniquement localisés à haut risque de progression (2010) (0)
Génétique des tumeurs germinales du testicule (2006) (0)
Iconographies supplémentaires de l'article : Nouveaux paradigmes et enjeux dans la prise en charge des cancers de la prostate (2017) (0)
Iconographies supplémentaires de l'article : Biologie moléculaire de la prostate normale et pathologique (2011) (0)
Formes familiales de cancer de la prostate: « marchesur le(s) gène(s) de prédisposition (1996) (0)
Évaluation du risque de récidive vésicale par la recherche de la mutation FGFR3 sur l’ADN urinaire prélevé avant néphro-uréterectomie pour le traitement d’une tumeur de la voie excrétrice supérieure (2015) (0)
Étude de la sexualité chez des patients traités par photovaporisation laser de prostate : une série prospective de 109 patients (2012) (0)
Valeur pronostique de la sous-classification pT3 des tumeurs de la voie excrétrice urinaire supérieure localisées dans les cavités pyélocalicielles (2015) (0)
Dépistage du cancer de la prostate: Quand et comment utiliser les PSA (2002) (0)
Étude de l’influence de l’expression de Foxp3 (Forkhead box protein) sur la survie des patients neuro-urologiques ayant une tumeur de vessie (2015) (0)
[Not Available]. (2014) (0)
Author Index and Subject Index (1998) (0)
FOXP3 est un marqueur tissulaire tumoral chez les patients neurologiques ayant une tumeur de vessie (2014) (0)
CHAPITRE 1. Les cancers hormonodépendants (2020) (0)
Tumeurs de la voie excrétrice supérieure : développement d’un modèle international postopératoire de prédiction de la survie après néphro-urétérectomie à l’aide de l’analyse des courbes de décision (2013) (0)
Validation externe du nomogramme prédictif de la récidive vésicale après néphro-urétérectomie totale pour le traitement des tumeurs de la voie excrétrice urinaire supérieure (2014) (0)
Corrélation des altérations génétiques à l’agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1 (2017) (0)
Urologie - Carcinomes urothéliaux de la voie excrétrice supérieure (2008) (0)
Impact de l’âge et de la densité du PSA sur la détection du cancer de prostate chez les patients avec IRM prostatique négative (2021) (0)
[Not Available]. (2014) (0)
Électroporation irréversible du cancer de la prostate localisé : résultats oncologiques et fonctionnels (2020) (0)
Revue systématique de la littérature et méta-analyse des facteurs de risque de récidive vésicale après néphro-uréterectomie totale pour le traitement d’une tumeur de la voie excrétrice urinaire supérieure (2015) (0)
Cancer de la prostate : passé, présent et futur (1998) (0)
Effets pharmacogénomique du Prostaphane® sur des cellules cancéreuses de prostate (2015) (0)
Facteurs de risque génétiques le cancer (2004) (0)
Comparaison du score de progression du cycle cellulaire (CCP) et de deux marqueurs immunohistochimiques (PTEN et KI67) pour la prédiction du cancer de la prostate après prostatectomie radicale (2017) (0)
Vers une nouvelle frontière (2011) (0)
Développer les stratégies de surveillance active (2010) (0)
La performance du test urinaire Xpert® Bladder Cancer Monitor est supérieure à celle de la cytologie pour la détection des récidives des tumeurs de la vessie n’infiltrant pas le muscle (2020) (0)
[Not Available]. (2014) (0)
[Not Available]. (2014) (0)
Prévalence et diversité de la prise en charge des patients atteints de cancer de la prostate classés à faible risque selon la classification de d’Amico ou le score de CAPRA : étude française multicentrique (2017) (0)
Thérapie génique du cancer de la prostate : principes et modalité d'application : Cancer de la prostate (1998) (0)
Rôle du polymorphisme génétique comme facteur de susceptibilité et d’agressivité du carcinome rénal à cellules claires (2012) (0)
[Not Available]. (2015) (0)
Culture cellulaire de l'épithélium prostatique humain normal, immortalisé et transformé : applications en cancérologie expérimentale (1994) (0)
[Not Available]. (2014) (0)
1582 SINGLE NUCLEOTIDE POLYMORPHISMS IN GENES REGULATING STEROID HORMONES METABOLISM ARE INDEPENDENTLY ASSOCIATED WITH INCREASED PROSTATE VOLUME (2012) (0)
Impact sur la composition corporelle et le style de vie du suivi personnalisé par télémédecine des patients traités pour un cancer de la prostate par association radio-hormonothérapie utilisant la leuproréline 45 mg (2018) (0)
[Not Available]. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Olivier Cussenot?

Olivier Cussenot is affiliated with the following schools:

Olivier Cussenot's Academic­Influence.com Rankings

Olivier Cussenot's Degrees

Why Is Olivier Cussenot Influential?

Olivier Cussenot's Published Works

Published Works

What Schools Are Affiliated With Olivier Cussenot?

Olivier Cussenot's AcademicInfluence.com Rankings